• Develop new and advanced imaging techniques and equipment for application in biomedicine;
• Foster the growth of Australian expertise in biomedical imaging and build the nation's capacity to serve the needs of researchers, clinicians and industry people working in this field.

CRCBID’s unique structure and mix of participants allows it to play a central role in all stages of the development process that has been identified for investigation - from the design of a new radiotracer right through to its detection in the human body, and on to the delivery for use in patients in a clinical setting.

CRCBID's two research streams are designed to work together to enable an improvement in the targeting and detection of diseases in their early stages.The Radiopharmaceuticals Stream aims to develop novel tracers that have a clear clinical application in humans based on identified clinical need. However, as the CRCBID is looking for very early signs of disease and the most specific of signals, the Detectors Stream is focused on developing more sensitive and better detection equipment.  Download brochure on the Detectors Research Stream here.

CRCBID unites for collaboration the wide ranging skills and experience of its participant organisations, and provides a focus and a mechanism for all stakeholders to process their ideas, conduct research, evaluate results and proceed to commercialisation, ensuring that the needs of all stakeholders in the final result are addressed and met.